Advisory Committee Conflict Of Interest Waivers Get Support From Study

FDA's policy of granting waivers for financial conflicts of interest for advisory committee members is getting support from an independent review. According to an analysis commissioned by the agency, constructing advisory committees free from conflicts of interest would be expensive and time-consuming and may be unfeasible for certain topics and fields of expertise